Pfizer in Asia Will Focus on Asia-Specific Diseases and Solutions

Pfizer will turn the focus of its Singapore clinical research unit toward Asia-specific diseases. In part, this means the unit will emphasize diseases that are more prevalent in Asia, diseases such as specific forms of cancer. It also means that Pfizer will investigate diseases that are prevalent around the global, but whose etiology in Asian populations may be different than in the rest of the world. Pfizer cited diabetes as an example of the latter category. More details... Stock Symbol: (NYSE: PFE)